Is ZSANQ or HDV a better dividend investment in 2026?

ZSANQ currently yields 1000000.00% with a 5% 5-year dividend growth rate. HDV yields 2.92% with 4.8% growth. The better choice depends on your goal: ZSANQ offers higher current income.

What is the dividend yield difference between ZSANQ and HDV?

ZSANQ has a forward dividend yield of 1000000.00% ($2.00/share annually). HDV yields 2.92% ($3.96/share annually). The yield gap is 999997.08 percentage points.

Home › Compare › ZSANQ vs HDV

ZSANQ vs HDV: Dividend Comparison 2026

ZSANQ yields 1000000.00% · HDV yields 2.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ZSANQ wins by $4.7683925249533696e+36M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ZSANQ

● Live price

1000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.7683925249533696e+36M

Annual income

$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00

Full ZSANQ calculator →

HDV

iShares Core High Dividend ETF

● Live price

2.92%

Share price

$135.39

Annual div

$3.96

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$24.3K

Annual income

$352.73

Full HDV calculator →

Portfolio growth — ZSANQ vs HDV

📍 ZSANQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ZSANQ	HDV
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ZSANQ + HDV cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ZSANQ pays

HDV pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZSANQ

Annual income on $10K today (after 15% tax)

$85,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr

HDV

Annual income on $10K today (after 15% tax)

$248.52/yr

After 10yr DRIP, annual income (after tax)

$299.82/yr

At 15% tax rate, ZSANQ beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZSANQ + HDV for your $10,000?

ZSANQ: 50%HDV: 50%

100% HDV50/50100% ZSANQ

Portfolio after 10yr

$2.3841962624766848e+36M

Annual income

$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.98%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZSANQ buys

HDV buys

No recent congressional trades found for ZSANQ or HDV in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricZSANQHDV

Forward yield	1000000.00% ✓	2.92%
Annual dividend / share	$2.00	$3.96 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$4.7683925249533696e+36M	$24.3K ✓
Annual income after 10y	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00 ✓	$352.73
Total dividends collected	$4.7683311610149396e+36M ✓	$3.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: ZSANQ vs HDV ($10,000, DRIP)

Year	ZSANQ Portfolio	ZSANQ Income/yr	HDV Portfolio	HDV Income/yr	Gap
1← crossover	$100,010,700	$100,000,000.00	$11,002	$292.38	+$100.00M → ZSANQ
2	$934,786,450,701	$934,679,439,252.34	$12,084	$300.36	+$934786.44M → ZSANQ
3	$8,165,787,108,578,292	$8,164,786,887,076,042.00	$13,250	$308.02	+$8165787108.57M → ZSANQ
4	$66,665,884,190,957,650,000	$66,657,146,798,751,470,000.00	$14,506	$315.35	+$66665884190957.63M → ZSANQ
5	$508,662,171,058,048,100,000,000	$508,590,838,561,963,700,000,000.00	$15,858	$322.35	+$508662171058048128.00M → ZSANQ
6	$3,627,235,248,428,489,700,000,000,000	$3,626,690,979,905,457,600,000,000,000.00	$17,313	$329.04	+$3.62723524842849e+21M → ZSANQ
7	$24,173,681,159,150,610,000,000,000,000,000	$24,169,800,017,434,790,000,000,000,000,000.00	$18,878	$335.42	+$2.417368115915061e+25M → ZSANQ
8	$150,567,402,861,454,640,000,000,000,000,000,000	$150,541,537,022,614,370,000,000,000,000,000,000.00	$20,560	$341.49	+$1.5056740286145463e+29M → ZSANQ
9	$876,477,100,281,847,600,000,000,000,000,000,000,000	$876,315,993,160,785,800,000,000,000,000,000,000,000.00	$22,367	$347.25	+$8.764771002818475e+32M → ZSANQ
10	$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00	$24,307	$352.73	+$4.7683925249533696e+36M → ZSANQ

ZSANQ vs HDV: Complete Analysis 2026

ZSANQ — Stock

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. On June 1, 2022, Zosano Pharma Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Full ZSANQ Calculator →

HDV — ETF

The iShares Core High Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full HDV Calculator →

📬

Get this ZSANQ vs HDV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZSANQ vs SCHD ZSANQ vs JEPI ZSANQ vs O ZSANQ vs KO ZSANQ vs MAIN ZSANQ vs VYM ZSANQ vs DVY ZSANQ vs SPHD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.